Bexxar
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
There is a long history of absorbed dose calculations being performed to evaluate the risks involved in the application of…
Currently, beta-emitting radionuclides are used almost exclusively in the clinic and in clinical radioimmunotherapy studies. The…
Eight years after being treated with a new drug for non-Hodgkin's lymphoma, 86 percent of patients were still alive and half had…
8089 Background: BTR has demonstrated efficacy in NHL patients and it has potential to prolong time to progression (TTP) in…
Advanced follicular lymphomas (FL) are incurable with conventional chemotherapy regimens. The Southwest Oncology Group…
6518 Background: The sequential combination of chemotherapy and radioimmunotherapy offers a novel strategy for the initial…
6575 Introduction: The Bexxar therapeutic regimen can produce durable and complete responses in patients with relapsed/refractory…
Waldenstrom's macroglobulinemia is an indolent B-cell malignancy that is characterized by high levels of IgM paraprotein…
Radioimmunotherapy (RIT) with Bexxar (tositumomab and iodine‐131 tositumomab; Coulter Pharmaceutical, South San Francisco, CA…